Citi’s Alicia Yap expects Baidu Inc (ADR)
Yap maintains a Neutral rating on the company with a price target of $196.
Capturing The Cloud
Yap noted that Baidu has been focused on rebranding Baidu Cloud, launching the medical AI Chabot and establishing Baidu Capital, in order to capture opportunities around Cloud, AI and Big Data.
“While we believe some of these strategic moves could potentially strengthen Baidu's overall business in the long term, we remain cautious on the near-term growth outlook due to stricter controls on account reviews and policies,” the analyst went on to say.
Yap expects Baidu to report its Q3:16 gross revenue at Rmb 18.21 billion, in line with the guidance but below the consensus expectations.
The non-GAAP EPS for the quarter is expected at Rmb 6.82, again below the consensus forecast, with non-GAAP operating margins of 15.2 percent.
“Given the on-going transition of its medical keywords impact and the uncertainty about the various approval timing of “advertising examination form”, we believe 4Q16E revs guidance could also be either in-line or slightly below consensus expectation,” the analyst mentioned.
For Q4, Yap expects revenues of Rmb 19.36 billion, with non-GAAP EPS of Rmb 7.32, below the consensus expectations.
“We believe Baidu is likely to provide 4Q16E rev outlook largely in-line or slightly soft compared to consensus expectations,” the analyst added.
Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email
|Sep 2016||Deutsche Bank||Downgrades||Buy||Hold|
|Aug 2016||JP Morgan||Assumes||Underweight|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.